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Abstract
Background: Nanotechnology and engineered nanomaterials (ENM) are here to stay. Recent evidence suggests
that exposure to environmental particulate matter exacerbates symptoms of asthma. In the present study we
investigated the modulatory effects of titanium dioxide particle exposure in an experimental allergic asthma.
Methods: Nonallergic (healthy) and ovalbumin-sensitized (asthmatic) mice were exposed via inhalation to two
different sizes of titanium dioxide particles, nanosized (nTiO2) and fine (fTiO2), for 2 hours a day, three days a week,
for four weeks at a concentration of 10 mg/m
3. Different endpoints were analysed to evaluate the immunological
status of the mice.
Results: Healthy mice elicited pulmonary neutrophilia accompanied by significantly increased chemokine CXCL5
expression when exposed to nTiO2. Surprisingly, allergic pulmonary inflammation was dramatically suppressed in
asthmatic mice which were exposed to nTiO2 or fTiO2 particles - i.e. the levels of leucocytes, cytokines, chemokines
and antibodies characteristic to allergic asthma were substantially decreased.
Conclusions: Our results suggest that repeated airway exposure to TiO2 particles modulates the airway
inflammation depending on the immunological status of the exposed mice.
Background
The exploding market of nanobased products and nano-
technology as a whole have put the health professionals
and regulatory authorities at an alert. There is already
growing evidence on the potential adverse health effects
on healthy individuals, but only part of the world’s
population can be categorized into this group. A large
part of the population has impaired health conditions
that will make them more susceptible to develop health
problems from particulate exposure.
In industrialized countries asthma and allergies are
increasingly prevalent. According to the European Acad-
emy of Allergy and Clinical Immunology (EAACI) one
in three children today is allergic and 30-50% of them
will develop asthma. It is estimated that by year 2015
half of all Europeans may be suffering from allergy [1].
Asthma is a product of both genetic predisposition and
environmental conditions. Children in wealthy countries
are more likely to develop allergy-related asthma than
children in poorer nations [2]. Hygiene hypothesis sug-
gests that lack of intense infections due to improved
hygiene, vaccination and antibiotics has altered the
immune system to improperly respond to neutral sub-
stances [3]. Approximately 80% of asthma cases today
are caused by allergies. Evidence already exists that
environmental particulate matter, such as air pollutants
and diesel exhaust particles, enhances airway hyperre-
sponsiveness and exacerbation of asthma as well as
increases respiratory and cardiovascular mortality and
morbidity [4-6]. The most susceptible population groups
for these adverse health effects include elderly subjects
with chronic cardiorespiratory disease, as well as chil-
dren and asthmatic subjects of all ages.
Nanosized and larger particles of titanium dioxide
(TiO2) are widely used in many fields of science and
technology. According to the IARC [7] titanium dioxide
accounts for 70% of the total production volume of
pigments worldwide and is classified as possibly
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used in various applications such as paints, coatings, UV
protection, photocatalysis, sensing and electrochromics,
photochromics as well as food colouring [8]. Brightness
and high refractive index are properties that have made
TiO2 the most widely used white pigment. Other prop-
erties of TiO2 include chemical stability, low toxicity
and cheap price. Plain TiO2 nanoparticles are often
altered to better and more specifically suit their uses.
Alterations can be made by doping TiO2 with other ele-
ments or by modifying the surface with other semicon-
ductor materials. TiO2 mostly occurs as rutile, anatase
or brookite chrystalline polymorphs.
I nt h ep r e s e n ts t u d yw ee x p l o r e dt h ee f f e c t so f
repeated inhalation exposure in asthmatic and healthy
mice to two different sizes of TiO2.W ed e m o n s t r a t e
that contrary to expectations exposure to fine or nano-
sized particles inhibits most soluble and cellular media-
tors of allergic asthma. The present study emphasizes
that it is crucial to take into account the heterogeneity
of the state of health of individuals in assessing health
implications of nanoparticle exposure in humans.
Materials and methods
Test materials
Two different types of titanium dioxide (TiO2)p a r t i -
cles were used in our experiments. The other TiO2
was nanosized and the other coarser fine-sized. The
fine rutile particle (fTiO2; product number 224227,
Sigma-Aldrich, Steinheim, Germany) had an initial par-
t i c l es i z eo fu n d e r5μm and nanosized rutile (nTiO2;
product number 637262, Sigma-Aldrich) was silica
coated, needle-like and ca. 10 × 40 nm in size. Both
materials were thoroughly characterized before and
during exposures (Figure 1, [9]). The size and mor-
phology of the nanopowders were characterized by
electron microscopy (Zeiss ULTRAplus FEG-SEM, Carl
Zeiss NTS GmbH, Oberkochen, Germany and JEM
2010 TEM, Jeol Ltd., Tokyo, Japan) and their composi-
tion by energy dispersive spectroscopy (EDS; Thermo-
Noran Vantage, Thermo Scientific, Breda, The
Netherlands). The crystallinity and phase composition
of the nanopowders were characterized by powder x-
ray diffraction analysis (Siemens D-500, Siemens AG,
Kahrlruhe, Germany) and specific surface area of nano-
powders was measured by nitrogen adsorption, using
the Brunauer-Emmett-Teller method (Coulter Omnis-
orp 100CX, Florida, USA).
Exposure system for aerosolized particles
The animals were exposed using a solid particle dispen-
ser (Rotating Brush Generator, RBG 1000, Palas, Karls-
ruhe, Germany) as described earlier by Rossi et al.
(2010).
Aerosol and particle characterization
The aerosol size distributions were measured from 10
nm to 1000 nm with a scanning mobility particle sizer
(SMPS) consisting of a
63Ni bipolar aerosol neutralizer,
a Vienna type differential mobility analyzer (DMA) with
length of 28 cm and TSI model 3010 condensation par-
ticle counter (CPC) [10]. Aerosol aerodynamic size dis-
tribution was measured from 15.9 nm to 10 μm with an
electronic low pressure impactor (ELPI, Dekati) (Figure 2)
[11]. The aerosol mass concentration was determined
gravimetrically after collection on nitrocellulose filters
(Millipore). Particle concentration inside the particle
dispenser chamber was also monitored using a
personal DataRAM (online mass concentration meter,
pDR1000AN, Waltham, MA, USA).
Animals - sensitization and exposure protocol
Following a 1-week acclimation period, 7-week-old female
BALB/c/Sca mice (Scanbur AB, Sollentuna, Sweden) were
randomized into two exposure and control groups
(8 mice/group). Mice were sensitized intraperitonally with
20 μg of ovalbumin (OVA) in alum (Sigma-Aldrich, St
Louis, MO) in 100 μl of phosphate-buffered saline (PBS)
on days 1 and 14 of the experiment. Control group was
g i v e na l u mi n1 0 0μl of PBS. Exposure groups were
exposed three times a week for 2 hours for the duration of
the four week experiment. The exposure concentration
was 10 ± 2 mg/m
3 in all tests. This concentration was cho-
sen to mimic occupational conditions where workers are
exposed to concentrations of around 5 mg/m
3 [12]. On
days 25-27 all mice were challenged with 1% OVA solu-
tion via the airways for 20 min administered using the
ultrasonic nebulizer (DeVilbiss, Glendale Heights, IL).
Measurement of airway responsiveness
Airway responsiveness was measured on day 28 using a
single chamber, whole-body plethysmograph system
(Buxco, Troy, NY) as described earlier [13]. Briefly, mice
were exposed to increasing concentrations (1, 3, 10, 30
and 100 mg/ml) of metacholine (MCh; Sigma Aldrich)
in PBS delivered via an AeroSonic 5000 D ultrasonic
nebulizer (DeVilbiss, ITW, Glendale Heights, IL). Before
MCh exposure the baseline is measured for three min-
utes. After baseline measurements the MCh is nebulized
for 1.5 minutes and airway reactivity is measured for
5 minutes per concentration. Lung reactivity parameters
were expressed as Penh (enhanced pause) values. After
measurement of lung responsiveness, the mice were
sacrificed using an overdoseo fi s o f l u r a n ea n ds a m p l e s
were collected for analysis.
Collection of biological samples and preparation
Sample collection and preparation were done as
described previously by Rossi et al. (2010). The
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body analysis, bronchoalveolar lavage (BAL) cells and
supernatant for May Grünwald-Giemsa (MGG) staining
and protein analysis and lung samples for RNA isolation
and hematoxylin and eosin (H&E) and Periodic Acid-
Schiff (PAS) staining. The spleens were also dissected
f r o mt h em i c eo n t o6 - w e l lp l a t e sw i t hP B Sf o rs p l e e n
cell stimulations.
Spleen cell stimulations
Spleens were mechanically broken down into paste and fil-
tered to remove larger pieces. Cells were resuspended in
RPMI media, counted under light microscopy and plated at
a concentration of one million cells/ml. Cells to be stimu-
lated were plated in RPMI containing 100 μg/ml ovalbumin.
All cells were incubated for 48 hours after which the super-
natant was collected and stored at -70°C prior to analysis.
Figure 1 Particle characteristics. Particles used in this study are listed in this table. All characteristics are measured by us as described in the
materials and methods section unless stated otherwise in the table. Pictures of nanoparticles are taken using scanning electron microscopy [9].
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Page 3 of 14Figure 2 Particle and aerosol characteristics. A) Particle mobility and aerodynamic number size distributions measured with SMPS. Size bin
concentrations are represented as mean (o), median (x) and standard deviation (box). Solid line represents mean of multi log-normal function
and dotted lines are means of single modes. Measurements and fitting were done during steady-state condition. B) Multi log-normal fit
parameters for Fig 2A. particle size distributions and mean particle concentration measured by CPC [32]. Dpg, i,N i and sg, i are geometric mean
diameter, particle concentration and geometric standard deviation of mode i, respectively, and Ntot is total particle concentration of size
distribution.
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RNA isolation from the lung tissues
The lung samples were homogenized in a FastPrep
FP120 (BIO 101, Thermo Savant, Waltham, Mass. USA)
-machine and RNA was extracted using the FastRNA
Pro Green Kit (Qbiogene/MP Biomedicals, Illkirch,
France) and its instructions.
cDNA synthesis
cDNA was synthesized from 1 μgo ft o t a lR N Ai na2 5
ul reaction using MultiScribe Reverse Transcriptase and
random primers (The High-Capacity cDNA Archive Kit,
Applied Biosystems, Foster City, CA) using the manu-
facturer’s protocol. The synthesis was performed in a
2720 Thermal Cycler (Applied Biosystems, Carlsbad,
California, USA) starting with 25°C for 10 minutes and
continuing with 37°C for 120 minutes.
Polymerase chain reaction (PCR) amplification
PCR primers and probes were ordered as pre-developed
assay reagents (18 S rRNA, TNFa,I L - 1 b, IL-4, IL-13,
IL-10, foxp3, CCL3, CXCL5 and CXCL2) from Applied
Biosystems (Carlsbad, California). The real-time quanti-
tative PCR was performed as described previously by
Rossi et al. (2010).
Enzyme-linked immunosorbent assay (ELISA)
TNF-a and IL-13 protein levels from spleen cell superna-
tants were determined using ELISA kits (eBioscience, San
Diego, CA, US) used according to manufacturer’s instruc-
tions. An ELISA plate microtiter reader (Multiskan MS,
Labsystems, Helsinki, Finland) was used to read the results.
Luminex
For analysis of TNF-a and IL-13 proteins in BAL fluid
supernatants we used a Milliplex Mouse Cytokine/Che-
mokine Immunoassay (Millipore Corporation, Billerica,
MA) according to the manufacturers’ protocol. 3%
bovine serum albumin (BSA; Sigma-Aldrich, St Louis,
MO) in PBS was added at a concentration of 0.5% to
samples, controls and standards to ensure sufficient pro-
tein amounts for the assay. Assay was performed using
Luminex xMAP Technology (Bio-Plex 200 System,
BioRad, Hercules, CA).
Measurement of serum antibodies
For the analysis of OVA-specific IgE, ELISA plates were
coated with Purified Rat Anti-mouse IgE antibody (BD
Biosciences, San Jose, CA) and incubated overnight. On
the second day the plates were blocked with 3% BSA in
PBS, serum samples (1:10 and 1:20 dilution) were added
to the plate and incubated overnight. Biotinylated OVA
was added and streptavidin horseradish peroxidase
(Pharmingen 13047E, BD Biosciences) followed by
ABTS solution (ABTS Microwell Peroxidase Substrate
System, KPL, Gaithersburg, MD). Absorption was read
at 405 nm with ELISA plate absorbance reader (Multis-
kan MS, Labsystems, Helsinki, Finland).
For OVA-specific IgG2a analysis, ELISA plates were
coated with ovalbumin (BD Biosciences) and incubated
overnight. On the second day the plates were blocked
with 3% BSA in PBS, serum samples (1:60, 1:180, 1:540
and 1:1620 dilution) were added to the plate and incu-
bated overnight. Biotinylated anti-mouse IgG2a (Phar-
mingen 02012 D, BD Biosciences) was added and
streptavidin horseradish peroxidase (BD Biosciences).
ABTS solution and peroxidase were mixed 50:50 and
added before reading absorption at 405 nm with ELISA
plate absorbance reader.
Analysis of mucus producing cells
The lung tissue was analysed from formalin-fixed, paraf-
fin-embedded sections. These sections were stained for
mucus secreting goblet cells using Periodic acid-Schiff
(PAS) -stain. The data was analyzed with Leica Image
Manager IM50 version 4.0 (Leica Microsystems Imaging
Solutions Ltd., Cambridge, UK). PAS+ cells were
counted as an average of PAS+ cells found in 100 μmo f
bronchus counted from three bronchioles of similar size
per mouse (n = 8 mice per group).
Hydroxyl radical (
￿OH) formation capacity
The
￿OH formation capacity was determined using the
benzoic acid probe as described earlier by Rossi et al.
(2010).
Statistical analysis
The toxicological data was analyzed with the Graph-
PadPrism software (GraphPadPrism Software, Inc., San
Diego, CA). For all statistical analysis we first performed
analysis of variance using one-way ANOVA (nonpara-
metric Kruskal-Walles test) and when the ANOVA was
positive we performed post-testing. The different mice
groups were compared using nonparametric Mann-
Whitney U - test. P-values less than 0.05 were consid-
ered statistically significant.
Results
Inhalation exposure to TiO2 particles reduces leukocyte
numbers and mucus secretion in the airways of asthmatic
mice
Asthmatic mice demonstrate increased numbers of eosi-
nophils and lymphocytes in the airways compared to
healthy controls. In healthy mice (PBS) there was a sig-
nificant 4.6-fold increase in the influx of neutrophils fol-
lowing exposure to nTiO2 (Figure 3) whereas the
numbers of macrophages, eosinophils and lymphocytes
remained unaffected. Exposure to fTiO2 had no effects
on any cells in the BAL of healthy mice. Surprisingly,
the numbers of eosinophils and lymphocytes, character-
istic features of allergic inflammation, were dramatically
reduced in asthmatic mice (OVA) after exposure to
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half following nTiO2 and increased 1.7-fold following
fTiO2 exposure in asthmatic mice. Changes in numbers
of pulmonary neutrophils remained nonsignificant.
Goblet cell hyperplasia in the lungs is a common fea-
ture of allergic asthma and mucus secreting PAS+ gob-
let cells are usually not present in bronchioles and
smaller conducting airways of mice [14]. Healthy mice
showed clear lungs with no mucus secreting cells (Fig-
ure 4A) whereas PAS+ cells were abundant in the bron-
chial epithelium of allergic mice (Figure 4B). Both TiO2
particles caused a drastic reduction in the numbers of
PAS+ cells in the allergic mice (Figure 4C nTiO2 and D
fTiO2). Both exposed groups showed a statistically sig-
nificant decrease in goblet cell numbers in the epithe-
lium (Figure 4E) after the particle exposure.
Airway reactivity to inhaled metacholine is significantly
affected by particle exposure
Airway hyperresponsiveness, a hallmark of asthma, was
measured by airway reactivity to increased doses of
inhaled metacholine (Mch). Exposure of OVA sensitized
Figure 3 Cell count in bronchoalveolar lavage fluid. The effect of titanium dioxide (TiO2) inhalation exposure performed for 2 hours a day,
three days a week, for four weeks at a concentration of 10 mg/m
3 on macrophage, eosinophil, neutrophil and lymphocyte infiltration to
bronchoalveolar lavage fluid (BALF) calculated from May-Grünwald-Giemsa (MGG)-stained cytospin slides with light microscopy (x80). Results are
shown as cells per high power field (HPF) for healthy (PBS) and allergic (OVA) mice exposed to nanosized (nTiO2) or fine (fTiO2) TiO2 or left
unexposed (-). From each slide the cells were counted from three fields from which an average was counted. N = 8 mice per group. The bars
represent mean ± SEM; * P < 0.05 and ** P < 0.01 significantly different from unexposed control; Mann-Whitney U test.
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Page 6 of 14Figure 4 Occurence of mucus producing cells in bronchioles. Periodic acid-Schiff (PAS) -stained mouse lung tissue, where mucus producing
goblet cells can be seen in colour red around the bronchioles. Tissue samples from unexposed healthy (A) and asthmatic (B) mice and
asthmatic mice exposed to nanosized (C; nTiO2) or fine (D; fTiO2) TiO2. (E) Effects of titanium dioxide exposure on the amount of mucus-
producing cells around the bronchioles. Results are indicated as the average of PAS+ cells/100 μm of bronchus counted from three bronchioles
per mouse (n = 8 mice per group) for healthy (PBS) and allergic (OVA) mice exposed to nanosized (nTiO2) or fine (fTiO2) TiO2 or left unexposed
(-). N = 8 mice per group. The bars represent mean ± SEM; * P < 0.05 significantly different from unexposed control; Mann-Whitney U test.
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way hyperreactivity (AHR) to the level of healthy mice.
On the contrary, exposure to fTiO2 (Figure 5B) slightly
increased the reactivity of the lungs, showing modest
exacerbation of asthmatic symptoms. We also exposed
PBS groups to TiO2 particles (data not shown) but no
difference on airway reactivity to inhaled metacholine
was found between them and unexposed PBS groups.
Particle exposure results in a dramatic inhibition of
proinflammatory, regulatory and Th2 cytokines in the
lungs of asthmatic mice
The mRNA expression of proinflammatory cytokines,
IL-1b and TNF-a (Figure 6A), was downregulated after
particle exposure to about half and third respectively in
asthmatic mice when compared to the nonexposed con-
trol. IL-1b and TNF-a levels were also reduced in half
in healthy (PBS) mice following exposure to fTiO2.
Similarly, Th2 type cytokines IL-4 and IL-13 (Figure
6B), which are present in asthmatic but not in healthy
mice, were significantly diminished after exposure to
both nTiO2 and fTiO2. To examine effects of particle
exposure on the regulatory machinery we measured
mRNA expression of major suppressive cytokine IL-10
and Foxp3, a marker of regulatory T-cells. fTiO2 expo-
sure reduced IL-10 levels by 2.5-fold and Foxp3 levels
by 4.5-fold. nTiO2 exposure again reduced IL-10 levels
by over 8-fold and Foxp3 levels by 2.3-fold (Figure 6C).
We also looked at if suppression in cytokine expression
could be seen at the protein level. Reduction in the pro-
tein levels of both TNF-a (Figure 6D) and IL-13 (Figure
6D) in the BAL from asthmatic mice exposed to TiO2
particles was observed with statistical significance (one-
way ANOVA) in IL-13 levels.
The same suppression phenomenon that was seen in
cytokines could be seen with all chemokines examined.
mRNA expression of proinflammatory CCL3 (Figure
7A) and neutrophil attracting CXCL5 and CXCL2 (Fig-
ure 7B) was decreased in asthmatic mice after exposure
to both used particles. In healthy mice exposure to
nTiO2 caused an almost 5-fold elevation of CXCL5
levels, corresponding to high levels of neutrophils seen
in the BALF of the same mice.
Inhibition of cytokine production in OVA-stimulated
spleen cells and reduction in OVA specific IgE levels
suggests systemic immune suppression following particle
exposure in asthmatic mice
To evaluate possible systemic effects of particle exposure
we also examined spleen cells from asthmatic nTiO2
exposed mice. Spleen cells were either stimulated with
OVA or left untreated. OVA stimulated cells express
TNF-a and IL-13 as expected, but when the mice had
been exposed to nTiO2 the protein levels were reduced
amply (Figure 8). These results suggest that there is
indeed a systemic response that can be shown from the
spleen cells.
Increased levels of allergen specific IgE antibodies
are characteristic feature of allergic asthma. To inves-
tigate effects of particle exposure on circulating anti-
bodies we examined the allergen specific IgE and
IgG2a levels. OVA sensitized mice show high levels of
OVA specific IgE, but exposure to fTiO2 reduces the
levels of OVA specific IgE significantly (Figure 9A).
On the contrary, no significant changes in the levels
of OVA specific IgE could be seen after exposure to
nTiO2 particles (Figure 9A). Levels of OVA specific
IgG2a were low and unaffected by particle exposure
(Figure 9B).
Figure 5 Airway responsiveness to metacholine. Effect of airway
responsiveness to metacholine (MCh) in allergic mice after exposure
to nanosized (A; nTiO2) or fine (B; fTiO2) TiO2 for 2 hours a day,
three days a week, for four weeks at a concentration of 10 mg/m
3
(n = 8 mice per group). Results are shown as enhanced pause
(Penh) values, dimensionless values that we used to empirically
monitor airway function, in relation to increasing doses (1-100 mg/ml)
of aerosolized MCh for healthy (PBS) and allergic (OVA) mice.
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Initial particle sizes of particles used in this study are for
fTiO2 <5μm and for nTiO2 10 · 40 nm as given by the
vendor. Aerosolized particles in our experiment occured
as agglomerates. Specific surface area of nTiO2 is 132
m
2/g while it’so n l y2m
2/g for fTiO2 (Figure 1). The
aerodynamic number size distributions indicate that
nTiO2 dispersed in air using the solid particle dispenser
occurred mostly as agglomerates of 100 nm at a number
concentration of 69 000 cm
-3 whereas fTiO2 occurred as
agglomerates of 1 μm at a number concentration of
8000 cm
-3 (Figure 2A and 2B). fTiO2 distribution consist
mainly of agglomerates of 0.1 - 2 μma sm e a s u r e du s i n g
ELPI. It can be concluded that in particle number con-
centration most fTiO2 are below 1 μm in size but parti-
cle mass concentration relies on over 1 μm particles.
Analysis of the hydroxyl radical formation capacity
using the benzoic acid probe showed that neither of the
used particles produced ￿OH-radicals in a systematic
dose-response pattern [9].
Figure 6 mRNA and protein expression of cytokines. Relative mRNA-expression in the lung tissue of (A) proinflammatory cytokines, IL-1b and
TNF-a, (B) Th2 type cytokines IL-4 and IL-13, (C) regulatory cytokine IL-10 and marker of regulatory T-cells Foxp3. Protein levels (pg/ml) of
proinflammatory cytokine TNF-a (D) and Th2-type cytokine IL-13 (E) in BAL supernatant of mice. Results are shown in relative units (RU) or (pg/
ml) for healthy (PBS) and allergic (OVA) mice exposed for 2 hours a day, three days a week, for four weeks at a concentration of 10 mg/m
3 to
nanosized (nTiO2) or fine (fTiO2) TiO2 or left unexposed (-). N = 8 mice per group. The bars represent mean ± SEM; * P < 0.05, ** P < 0.01, and
*** P < 0.001 significantly different from unexposed control; Mann-Whitney U test.
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We reported recently that repeated inhalation exposure
to silica coated rutile titanium dioxide nanoparticles
(nTiO2) induces pulmonary neutrophilia accompanied
by expression of relevant cytokines and chemokines in
healthy mice [9]. Out of five different TiO2 particles this
was the only one that was slightly toxic. The purpose of
the present study was to examine immunomodulatory
effects of inhalation exposure to different sized particles,
nTiO2 and fine TiO2 (fTiO2) in OVA-sensitized, allergic
mice. Interestingly, inhalation exposure to both nano-
sized and fine TiO2 caused local and systemic inhibition
of several features of experimental asthma. Our results
indicate that particle exposure can modulate airway
inflammation and airway hyperreactivity in quite distinct
ways depending on the immune status of the animals.
Present results obtained from healthy mice were in
line with results from our previous study. Exposure to
nTiO2 particles caused an influx of pulmonary neutro-
phils and an expression of neutrophil attracting chemo-
kine CXCL5. When healthy mice inhaled fTiO2 the
mRNA expression of two proinflammatory cytokines,
TNF-a and IL-1b respectively, was suppressed. There
have been a limited number of relevant studies done
with inhalation and the results have been contradictory.
Some studies have reported pulmonary neutrophilia
Figure 7 mRNA expression of chemokines. mRNA expression of proinflammatory chemokine CCL3 (A) and neutrophil attracting chemokines
CXCL5 and CXCL2 (B) in the lung tissue of mice. Results are shown in relative units (RU) for healthy (PBS) and allergic (OVA) mice exposed for
2 hours a day, three days a week, for four weeks at a concentration of 10 mg/m
3 to nanosized (nTiO2) or fine (fTiO2) TiO2 or left unexposed (-).
N = 8 mice per group. The bars represent mean ± SEM; * P < 0.05, ** P < 0.01, and *** P < 0.001 significantly different from unexposed control;
Mann-Whitney U test.
Rossi et al. Particle and Fibre Toxicology 2010, 7:35
http://www.particleandfibretoxicology.com/content/7/1/35
Page 10 of 14after exposure to TiO2 nanoparticles whereas others
have not [15-20]. Comparison of these ENM is difficult
due to different or insufficient methods of particle char-
acterisation. There are also few cases of inhalation expo-
sure reported in humans reporting that inhalation of
titanium dioxide may cause metal fume fever [21] or
respiratory symptoms accompanied by reduction in pul-
monary function [22].
Epidemiological studies have shown that underlying
respiratory disease may critically affect the severity of
the symptoms when exposed to particulate air pollution
[4-6]. The most susceptible population groups for these
adverse effects include especially asthmatic subjects of
a l la g e s .I nt h ep r e s e n ts t u d yw ee x a m i n e dw h e t h e r
the asthmatic mice were more susceptible to develop
airway inflammation in response to exposure to TiO2
Figure 8 Protein levels of plated spleen cells. Protein levels (pg/ml) of TNF-a and IL-13 in the supernatant of plated spleen cells extracted
from allergic mice exposed to nTiO2 for 2 hours a day, three days a week, for four weeks at a concentration of 10 mg/m
3 or left unexposed (-).
Cells were either stimulated with OVA or left untreated. N = 8 mice per group. The bars represent mean ± SEM; * P < 0.05 significantly different
from unexposed control; Mann-Whitney U test.
Figure 9 Expression of antibodies. Levels of ovalbumin (OVA) specific antibodies IgE (A) and IgG2a (B). Results are shown in relative units (RU)
for healthy (PBS) and allergic (OVA) mice exposed for 2 hours a day, three days a week, for four weeks at a concentration of 10 mg/m
3 to
nanosized (nTiO2) or fine (fTiO2) TiO2 or left unexposed (-). N = 8 mice per group. The bars represent mean ± SEM; ** P < 0.01 significantly
different from unexposed control; Mann-Whitney U test.
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surprise exposure to fTiO2 and nTiO2 significantly
downregulated Th2 type inflammation in allergic mice
by preventing the infiltration of eosinophils and lympho-
cytes to the lungs, inhibiting the expression of Th2 cyto-
k i n e si nt h eB A La sw e l la sd e c r e a s i n gt h en u m b e r so f
mucus producing goblet cells in the airway epithelium.
To find out whether the observed suppression was also
a systemic phenomenon we stimulated spleen cells from
the asthmatic mice with OVA. Stimulated cells derived
from asthmatic mice readily expressed TNF-a and IL-13
protein, but cells from asthmatic mice that had been
exposed to nTiO2 lacked expression of these proteins
suggesting that suppression was indeed a systemic effect.
Increased airway hyperreactivity (AHR) to inhaled
methacholine (MCh) is one of the hallmarks of allergic
asthma. It was of interest that different size TiO2 parti-
cles acted differently on AHR in the present study.
Exposure to nTiO2 reduced OVA induced AHR to the
baseline level of non-sensitized mice whereas exposure
to fTiO2 did not have any suppressive effect - actually
fTiO2 exposed asthmatic mice exhibited slightly higher
levels of AHR compared to asthmatic mice without
fTiO2 exposure. Since IL-13 is known to be closely
involved in the development of AHR [23] it can be
speculated that reduction of AHR seen in nTiO2
exposed mice may at least partly be explained by dimin-
ished levels of IL-13 in the airways. On the other hand,
fTiO2 exposed mice also demonstrated reduced levels of
IL-13 mRNA and protein in the airways but their AHR
was not suppressed. Thus, yet unidentified factors regu-
lating AHR are likely to play an important role in the
modulation of AHR responses during TiO2 particle
exposure. Th2 cytokines IL-13 and IL-4 also control
mucus production and their suppression may explain
the clear-cut reduction of goblet cells in the airway
epithelia. It is worth mentioning that some differences
in the absolute values of Penh were observed in PBS
and OVA groups between the two experiments (i.e. Fig-
ure 5A and 5B). We want to emphasize that although
the scale of Penh values differed between the two
experiments, the relative difference between PBS and
OVA groups was almost identical. We can therefore
quite reliably conclude that the particles studied exhib-
ited different effects on airway reactivity in relation to
PBS and OVA groups in these study settings.
Suppression of inflammation similar to the one seen
in the present study has been previously reported in the
context of exposure to soot and iron oxide [24], oak
dust [25], cigarette smoke [26] and fullerenes [27].
Exposure of asthmatic mice to oak dust resulted in sup-
pression of airway reactivity, IL-13, IFN-g,C X C L 5 ,
CXCL2/3 and neutrophils [25]. Thacher et al. (2008)
reported reduction in eosinophil numbers, PAS+ cells,
IL-5, IL-4 and total IgE. Fullerene exposure caused inhi-
bition of anaphylaxis [27]. In contrast to present find-
ings Larsen et al. [28] reported that TiO2 nanoparticles
exhibited a strong adjuvant effect on the development of
Th2 dominant immune response in the ovalbumin aller-
gic asthma model. The particles were delivered intraper-
itonally (IP), which is an unnatural exposure route to
nanoparticles in real life. In our study we examined the
e f f e c t so fa i r w a ye x p o s u r et oT i O 2 particles, which bet-
ter mimics the real-life exposure scenario. It is impor-
tant to note that unlike the particles that people more
often get exposed to, such as air pollutants and mold,
the particles we studied were free of bioactive organic
matter. Organic matter contains pathogen-associated
molecular patterns that activate innate immunity and
cause an enhanced response in allergic mice. In line
with this we reported previously [29] that mold expo-
sure together with allergen sensitization caused dramati-
cally enhanced and qualitatively different pulmonary
inflammation. The present results demonstrate that
exposure to microbe free TiO2 particles may not
increase Th2 associated airway inflammation and aller-
gic airway hyperreactivity. It should be noted, however,
that asthmatic symptoms are not always Th2 associated
and therefore responses of exposure to TiO2 particles in
patients with non-allergic asthma may differ from the
present study.
It can be hypothesized that anti-inflammatory Th2
response caused by allergen sensitization may be sup-
pressed by the competing proinflammatory response eli-
cited by TiO2 exposure. On the other hand, it has been
suggested that T-cell dysfunction results in systemic
immune suppression in mice exposed to multiwalled
carbon nanotubes [30]. Also in the case of cigarette
smoke exposure, reduced T helper function was consid-
ered as one possible reason for the suppression of aller-
gic symptoms. Furthermore, consensus exists that Foxp3
+ regulatory T-cells are able to control the inflammation
thus preventing overactive inflammatory process that
harms hosts’ own tissue. We therefore also investigated
whether the exposure to TiO2 particles induces elevated
levels of Foxp3, a marker of regulatory T-cells, as well
as regulatory cytokine IL-10. Expression levels of Foxp3
and IL-10 were, however, significantly inhibited in asth-
matic mice by the particle exposure excluding the possi-
bility that suppression was mediated mainly via
regulatory T-cells and regulatory cytokines.
Conclusions
Assessing risks associated with particle exposure is com-
plicated. This study accentuates that attention has to be
paid not only to various characteristics of particles but
to various health conditions of people being exposed to
them. An interesting study emphasizes these results
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matory responses to otherwise inert TiO2 particles and
caused increased allergic susceptibility in their offspring
[31]. Very little is known about the physicochemical
characteristics which are associated with harmful toxico-
logical potential of nanoparticles. In the present study,
the inflammatory potential was not associated with par-
ticle size. Even though results slightly varied between
the two TiO2 particles examined the main mechanism
induced by particle exposure in the context of allergic
asthma was suppression of Th2 type inflammation.
Further studies are needed to provide a better founda-
tion for easier and more reliable assessment and man-
agement of risks of nanosized and larger particles.
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